National Health (Listed drugs on F1 or F2) Amendment Determination 2015 (No. 4) (PB 52 of 2015)

Link to law: https://www.comlaw.gov.au/Details/F2015L00755

 
PB 52 of 2015
 
National Health (Listed drugs on F1 or F2) Amendment Determination 2015 (No. 4)
National Health Act 1953
I, ADRIANA PLATONA, Assistant Secretary , Pharmaceutical Evaluation Branch, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this determination under subsection 85AB(1) of the National Health Act 1953.
Dated          27 May 2015
 
 
 
 
 
 
 
 
 
ADRIANA PLATONA
 
Assistant Secretary
Pharmaceutical Evaluation Branch
Pharmaceutical Benefits Division
Department of Health
 
 
 
 
Part 1         Preliminary
1              Name of Determination
         (1)   This Determination is the National Health (Listed drugs on F1 or F2) Amendment Determination 2015 (No. 4).
         (2)   This Determination may also be cited as PB 52 of 2015.
2              Commencement
                This Determination commences on 1 June 2015.
3              Amendment of National Health (Listed drugs on F1 or F2) Determination 2010
                Schedule 1 amends the National Health (Listed drugs on F1 or F2) Determination 2010 (PB 93 of 2010).
Schedule 1             Amendments
 
(Section 3)
 
 
[1]     Schedule 1, after item dealing with Amylopectin, modified long chain
 
Insert
 
Anakinra
 
[2]     Schedule 1, after item dealing with Cabazitaxel
 
Omit
 
Calcipotriol
 
 
Read Entire Law on www.comlaw.gov.au